Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.

Jameson GS, LeGrand SD, Gordon MS, Roe DJ, Wertheim BC, Olszewski K, Rabinowitz J, Evans R, Downes M, Truitt M, Korn R, Han H, Miller RM, Barrett MT, Propper D, Von Hoff DD, Borazanci E

Open source

DOI: 10.1016/j.redox.2025.103895
Published: 2025 Dec
Container: Redox biology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.redox.2025.103895,
  title = {Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.},
  author = {Jameson GS and LeGrand SD and Gordon MS and Roe DJ and Wertheim BC and Olszewski K and Rabinowitz J and Evans R and Downes M and Truitt M and Korn R and Han H and Miller RM and Barrett MT and Propper D and Von Hoff DD and Borazanci E},
  year = {2025},
  journal = {Redox biology},
  doi = {10.1016/j.redox.2025.103895},
  url = {https://doi.org/10.1016/j.redox.2025.103895}
}

RIS

TY  - JOUR
TI  - Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
AU  - Jameson GS
AU  - LeGrand SD
AU  - Gordon MS
AU  - Roe DJ
AU  - Wertheim BC
AU  - Olszewski K
AU  - Rabinowitz J
AU  - Evans R
AU  - Downes M
AU  - Truitt M
AU  - Korn R
AU  - Han H
AU  - Miller RM
AU  - Barrett MT
AU  - Propper D
AU  - Von Hoff DD
AU  - Borazanci E
PY  - 2025
JO  - Redox biology
DO  - 10.1016/j.redox.2025.103895
UR  - https://doi.org/10.1016/j.redox.2025.103895
ER  -

APA

GS, J., SD, L., MS, G., DJ, R., BC, W., K, O., J, R., R, E., M, D., M, T., R, K., H, H., RM, M., MT, B., D, P., DD, V. H., & E, B. (2025). Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.. Redox biology. https://doi.org/10.1016/j.redox.2025.103895

Source records

pubmed · retrieved 2026-09-26T01:44:37.544Z
europe-pmc · retrieved 2026-09-26T01:44:38.092Z
doaj · retrieved 2026-09-26T01:44:37.567Z